BRPI0822069B8 - método para preparação de um extrato de fruta de cardo leiteiro - Google Patents

método para preparação de um extrato de fruta de cardo leiteiro

Info

Publication number
BRPI0822069B8
BRPI0822069B8 BRPI0822069A BRPI0822069A BRPI0822069B8 BR PI0822069 B8 BRPI0822069 B8 BR PI0822069B8 BR PI0822069 A BRPI0822069 A BR PI0822069A BR PI0822069 A BRPI0822069 A BR PI0822069A BR PI0822069 B8 BRPI0822069 B8 BR PI0822069B8
Authority
BR
Brazil
Prior art keywords
preparing
milk thistle
fruit extract
extract
thistle fruit
Prior art date
Application number
BRPI0822069A
Other languages
English (en)
Inventor
Nagell Astrid
Xiol Aguirre Jaime
Rull Prous Santiago
Original Assignee
Euromed Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Euromed Sa filed Critical Euromed Sa
Publication of BRPI0822069A2 publication Critical patent/BRPI0822069A2/pt
Publication of BRPI0822069B1 publication Critical patent/BRPI0822069B1/pt
Publication of BRPI0822069B8 publication Critical patent/BRPI0822069B8/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/28—Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00—General protective or antinoxious agents
    • A61P39/02—Antidotes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
    • A61K2236/30—Extraction of the material

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Botany (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Medical Informatics (AREA)
  • Biotechnology (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Virology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Molecular Biology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Toxicology (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

método para preparação de um extrato de fruta e cardo leiteiro, preparação farmacêutica compreendendo o referido extrato, bem como uso do mesmo. a presente invenção refere-se a um método para preparação de um extrato de frutas de cardo leiteiro, em particular uma preparação de flavanolignano possuindo uma taxa aumentada de liberação e melhor absorbabilidade, e seu uso, em particular para o tratamento e prevenção de doenças hepáticas.
BRPI0822069A 2007-12-23 2008-12-23 método para preparação de um extrato de fruta de cardo leiteiro BRPI0822069B8 (pt)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
DE102007063115 2007-12-23
DE102007063115.6 2007-12-23
DE102008039271.5 2008-08-23
DE102008039271A DE102008039271A1 (de) 2007-12-23 2008-08-23 Neuer Mariendistelextrakt, Verfahren zur Herstellung und Verwendung
PCT/DE2008/002117 WO2009080006A2 (de) 2007-12-23 2008-12-23 Neuer mariendistelextrakt, verfahren zur herstellung und verwendung

Publications (3)

Publication Number Publication Date
BRPI0822069A2 BRPI0822069A2 (pt) 2015-06-23
BRPI0822069B1 BRPI0822069B1 (pt) 2019-10-08
BRPI0822069B8 true BRPI0822069B8 (pt) 2021-05-25

Family

ID=40690102

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI0822069A BRPI0822069B8 (pt) 2007-12-23 2008-12-23 método para preparação de um extrato de fruta de cardo leiteiro

Country Status (20)

Country Link
US (1) US20110027396A1 (pt)
EP (2) EP2222320B1 (pt)
JP (2) JP5442632B2 (pt)
KR (2) KR101607445B1 (pt)
CN (2) CN101925360A (pt)
AU (1) AU2008340922B2 (pt)
BR (1) BRPI0822069B8 (pt)
CA (2) CA2922846A1 (pt)
CY (1) CY1115081T1 (pt)
DE (1) DE102008039271A1 (pt)
DK (1) DK2222320T3 (pt)
ES (1) ES2438003T3 (pt)
HK (1) HK1203352A1 (pt)
HR (1) HRP20131165T1 (pt)
MX (1) MX2010006982A (pt)
PL (1) PL2222320T3 (pt)
PT (1) PT2222320E (pt)
RU (1) RU2489161C2 (pt)
SI (1) SI2222320T1 (pt)
WO (1) WO2009080006A2 (pt)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PT2430017T (pt) * 2009-05-14 2016-10-12 Madaus Gmbh Método para a preparação de silibinina amorfa
CN102225085B (zh) * 2011-06-20 2012-09-05 黑龙江大学 一种从水飞蓟秸秆中提取水飞蓟总黄酮的方法
KR101316806B1 (ko) * 2011-08-02 2013-10-10 (주)이뮤노텍 글루타치온과 실리마린을 유효성분으로 함유하는 항산화 및 간보호용 조성물
KR101655396B1 (ko) * 2013-08-06 2016-09-08 에스케이바이오랜드 주식회사 수용성 밀크씨슬 추출물 및 이의 제조방법
JP2015113332A (ja) * 2013-12-16 2015-06-22 花王株式会社 生薬粉体
CN104744447B (zh) * 2013-12-31 2017-12-26 天士力制药集团股份有限公司 水飞蓟宾迷迭香酸酯及其制备方法和用途
CN104651037A (zh) * 2014-01-17 2015-05-27 吴长军 一种亚临界流体萃取水飞蓟籽仁中油脂和蛋白的方法
CN105622594B (zh) * 2016-03-17 2019-05-17 江苏中兴药业有限公司 一种高纯度水飞蓟素的制备方法
ES2706008B8 (es) * 2017-09-22 2021-07-12 Euromed S A Procedimiento para la preparacion de una composicion a partir del cardo mariano y composicion obtenida
KR102242002B1 (ko) 2019-02-21 2021-04-19 주식회사 노바케이메드 동충하초균사체로 고상발효된 홍삼 추출물을 유효성분으로 함유하는 지방간 질환 예방 또는 치료용 조성물
CN111518090B (zh) * 2020-05-12 2021-08-10 沈阳药科大学 黄烷黄酮衍生物及其制备方法和用途
KR102669644B1 (ko) * 2023-06-27 2024-05-27 한국자연한방 주식회사 실리마린 생체이용률이 증대된 밀크씨슬 추출물을 포함하는 지방간 개선, 예방 또는 치료용 조성물

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE1767666C3 (de) 1968-06-01 1986-07-31 Dr. Madaus & Co, 5000 Koeln Pharmazeutische Zubereitung gegen Lebererkrankungen
DE1923982C3 (de) 1969-05-10 1978-07-13 Hoechst Ag, 6000 Frankfurt Flammfestmachen von Polyurethanschaumstoffen
DE2020407A1 (de) 1970-04-27 1971-11-11 Bernhard Dr Janiak Technisches Verfahren zur Isolierung von Silimarin
FR2181188A5 (en) * 1972-04-20 1973-11-30 Dott Inverni Della Beffa Polyhydroxyphenylchromones - by solvent extn of non-defatted fruit of Silybum marianum
US4061765A (en) * 1973-01-19 1977-12-06 Dr. Madaus & Co. Polyhydroxyphenylchromanone salts and therapeutic composition
DD112261A1 (pt) * 1974-06-18 1975-04-05
DE2914330A1 (de) 1979-04-09 1980-10-30 Madaus & Co Dr Verfahren zur gewinnung von silymarin aus pflanzen
CH646695A5 (en) * 1980-10-06 1984-12-14 Madaus & Co Dr Method of obtaining silymarin from plants
DE3225688A1 (de) * 1982-07-09 1984-01-12 Suschnik Matthias Dr Verfahren zur gewinnung von silymarin aus silybum marianum
IT1241673B (it) 1989-10-09 1994-01-27 Istituto Biochimico Italiano Complessi di inclusione di silibinina con ciclodestrina, loro preparazione e composizioni farmaceutiche che li contengono.
DE19501266A1 (de) 1995-01-18 1996-07-25 Madaus Ag Verfahren zur Herstellung von Flavano-Lignan-Zubereitungen mit verbesserter Freisetzung und Resorbierbarkeit danach erhältliche Zubereitungen und deren Verwendung zur Herstellung von Arzneimitteln
KR0161349B1 (ko) 1995-01-20 1998-11-16 무라따 야스따까 압전 자기 조성물
RU2102999C1 (ru) * 1996-07-10 1998-01-27 Куркин Владимир Александрович Способ получения экстракта расторопши пятнистой
DE19744459A1 (de) 1997-10-08 1999-04-15 Schwabe Willmar Gmbh & Co Flavonolignan-Zubereitungen, insbesondere Silymarin-Zubereitungen
IN192343B (pt) * 2000-05-26 2004-04-10 Ranbaxy Lab Ltd
CZ292832B6 (cs) 2001-08-30 2003-12-17 Ivax Pharmaceuticals S.R.O. Způsob přípravy silymarinu se zvýšenou rozpustností
JP2003135023A (ja) 2001-10-30 2003-05-13 Os Kogyo Kk 健康食品
US7238373B2 (en) * 2003-04-04 2007-07-03 Nutritox Llc Nutritional supplement

Also Published As

Publication number Publication date
PT2222320E (pt) 2013-12-23
JP2011507812A (ja) 2011-03-10
BRPI0822069A2 (pt) 2015-06-23
DK2222320T3 (da) 2013-12-16
SI2222320T1 (sl) 2014-01-31
AU2008340922A1 (en) 2009-07-02
RU2010130855A (ru) 2012-01-27
EP2222320A2 (de) 2010-09-01
MX2010006982A (es) 2010-12-06
WO2009080006A3 (de) 2009-10-08
BRPI0822069B1 (pt) 2019-10-08
CA2922846A1 (en) 2009-07-02
ES2438003T3 (es) 2014-01-15
KR101607445B1 (ko) 2016-03-29
RU2489161C2 (ru) 2013-08-10
HRP20131165T1 (hr) 2014-01-03
CY1115081T1 (el) 2016-12-14
JP5442632B2 (ja) 2014-03-12
CA2709947A1 (en) 2009-07-02
CN101925360A (zh) 2010-12-22
PL2222320T3 (pl) 2014-02-28
US20110027396A1 (en) 2011-02-03
EP2567703A3 (de) 2013-03-20
AU2008340922B2 (en) 2012-07-19
WO2009080006A2 (de) 2009-07-02
CN104189043A (zh) 2014-12-10
KR20100126272A (ko) 2010-12-01
EP2222320B1 (de) 2013-09-18
CA2709947C (en) 2016-05-17
HK1203352A1 (en) 2015-10-30
DE102008039271A1 (de) 2009-06-25
EP2567703A2 (de) 2013-03-13
KR20150038663A (ko) 2015-04-08
JP2014074051A (ja) 2014-04-24
KR101541938B1 (ko) 2015-08-04

Similar Documents

Publication Publication Date Title
BRPI0822069B8 (pt) método para preparação de um extrato de fruta de cardo leiteiro
BR112015003397A2 (pt) composto, composição farmacêutica, uso do composto e método para tratar uma doença ou condição mediada por rorgammat em um paciente.
BR112015003332A2 (pt) composto, composição farmacêutica, uso do composto e método para tratar uma doença ou condição mediada por rorgammat em um paciente
BR112015003398A2 (pt) composto, composição farmacêutica, uso do composto e método para tratar uma doença ou condição mediada por rorgammat em um paciente
PL2731947T3 (pl) Podstawiona dimeryczna pochodna chinazoliny, sposób jej wytwarzania i jej zastosowanie w kompozycjach farmaceutycznych do leczenia cukrzycy typu I i II
BR112015002541A2 (pt) composto, composição farmacêutica, uso de um composto, e, método para tratamento de hcv em um paciente.
IL223783B (en) Compound 1-converted indole for use in the treatment of a disease or condition, a pharmaceutical preparation containing the compound and use of the compound to prepare a medicine
CO6280490A2 (es) 4-(4-ciano-2-tioaril)dihidropirimidinonas y su uso
MX2013008850A (es) Composiciones y metodos para tratar enfermedades cardiovasculares.
ECSP13012379A (es) Pirimidinas y triazinas condensadas y su uso
IL231536A (en) Indazole-3-carboxamides, pharmaceuticals containing them and their use in the treatment of diseases
AP2012006135A0 (en) Pharmaceutical composition, pharmaceutical dosage form, process for their preparation, methods for treating and uses thereof.
UY33370A (es) Composiciones farmacéuticas comprendiendo un fármaco inhibidor de la DPP4 y de la pioglitazona, procedimientos de preparación y utilización
BRPI0812851A2 (pt) Composto, composição farmacêutica, métodos para o tratamento de uma doença e de uma condição em um indivíduo, processo para preparar um composto, e, uso de um composto
BR112014008294A2 (pt) anticorpo anti c-met e usos do mesmo
EA033067B1 (ru) Способ лечения метаболических расстройств у пациента, имеющего противопоказание к назначению бигуанидного соединения
WO2014049447A3 (en) A whole, leech saliva extract
ES2542042R1 (es) Composiciones farmacéuticas y uso para preparar un medicamento destinado al tratamiento de la obesidad, los trastornos metabólicos relacionados y la adicción a sustancias psicoactivas
BR112013033078A2 (pt) partícula, composição farmacêutica, conjunto para o tratamento do câncer e método para o tratamento do câncer em um paciente
BR112013031712A2 (pt) composto, composição farmacêutica, métodos para preparar um composto e para o tratamento de um distúrbio ou uma doença.
ZA201203281B (en) Pharmaceutical combinations, pharmaceutical compositions, medicament and method for the treatment of animals
BR112012003280A2 (pt) composição farmacêutica para administração oral, método para tratar uma doença, uso do composto, e, composto.
ES2425315R1 (es) Composición farmacéutica y su uso para preparar un medicamento destinado al tratamiento sintomático de una enfermedad o afección respiratoria
WO2012125981A3 (en) Raf kinase inhibitors
BR112015006656A8 (pt) composições e métodos para o tratamento de insuficiência cardíaca em pacientes diabéticos

Legal Events

Date Code Title Description
B06F Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette]
B07D Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette]
B07E Notification of approval relating to section 229 industrial property law [chapter 7.5 patent gazette]
B06T Formal requirements before examination [chapter 6.20 patent gazette]
B06A Patent application procedure suspended [chapter 6.1 patent gazette]
B09A Decision: intention to grant [chapter 9.1 patent gazette]
B16A Patent or certificate of addition of invention granted [chapter 16.1 patent gazette]

Free format text: PRAZO DE VALIDADE: 10 (DEZ) ANOS CONTADOS A PARTIR DE 08/10/2019, OBSERVADAS AS CONDICOES LEGAIS. (CO) 10 (DEZ) ANOS CONTADOS A PARTIR DE 08/10/2019, OBSERVADAS AS CONDICOES LEGAIS

B16C Correction of notification of the grant [chapter 16.3 patent gazette]

Free format text: PRAZO DE VALIDADE: 20 (VINTE) ANOS CONTADOS A PARTIR DE 23/12/2008 OBSERVADAS AS CONDICOES LEGAIS. PATENTE CONCEDIDA CONFORME ADI 5.529/DF